Oncolytic Virus Promotes Tumor-Reactive Infiltrating Lymphocytes for Adoptive Cell Therapy

Adoptive cell therapy (ACT) using tumor-specific tumor-infiltrating lymphocytes (TILs) has demonstrated success in patients where tumor-antigen specific TILs can be harvested from the tumor, expanded, and re-infused in combination with a preparatory regimen and IL-2. One major issue for non-immunoge...

Descripción completa

Detalles Bibliográficos
Autores principales: Feist, Mathilde, Zhu, Zhi, Dai, Enyong, Ma, Congrong, Liu, Zuqiang, Giehl, Esther, Ravindranathan, Roshni, Kowalsky, Stacy J., Obermajer, Natasa, Kammula, Udai S., Lee, Andrew J. H., Lotze, Michael T., Guo, Zong Sheng, Bartlett, David L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9718357/
https://www.ncbi.nlm.nih.gov/pubmed/32632271
http://dx.doi.org/10.1038/s41417-020-0189-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9718357/
https://www.ncbi.nlm.nih.gov/pubmed/32632271
http://dx.doi.org/10.1038/s41417-020-0189-4

Ejemplares similares